QTMeds

Drug Database Monograph

FASENRA 30 mg

PENDING REVIEW

Active Ingredient: BENRALIZUMAB

QTc Interval Status:

neutral

Clinical Description (Database Summary)

Scientific Sources / References

Analyse RCP (Automatique), id : 63562134

← Back to Prescription Analyzer